Current Clinical Guidelines for the Management of Patients with Eosinophilic Esophagitis
Pediatric pharmacology · 26.07.2026 · 23 (3) · 220-251
DOI: 10.15690/pf.v23i3.3066 ↗Kurz gefasst
Leitlinie in der Zeitschrift Pediatric pharmacology, online erschienen am 26.07.2026. Verfasst von Oksana M. Drapkina und 39 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 181 Literaturangaben.
Abstract (Originalsprache)
This article presents an analysis of current clinical guidelines for the management of patients with eosinophilic esophagitis (EoE) — a chronic immune-mediated disease of the esophagus characterized by eosinophilic infiltration of the mucosa (≥ 15 eos/hpf) and clinical manifestations of esophageal dysfunction. The review highlights key changes in diagnostic approaches and discusses contemporary treatment strategies, including dietary therapy (starting with the least restrictive diets), pharmacological treatment (proton pump inhibitors, topical steroids, biologic therapy), and endoscopic dilation for strictures. The authors emphasize the need for comprehensive monitoring (clinical, endoscopic, and histological) to assess treatment response and for long-term maintenance therapy given the chronic nature of the disease. Special attention is paid to pediatric aspects of patient management.
Zitieren
APA
Drapkina, O. M., Ivashkin, V. T., Maev, I. V., Namazova-Baranova, L. S., Baranov, A. A., Khaitov, M. R., Mikhaleva, L. M., Kaybysheva, V. O., Vishneva, E. A., Fedorov, E. D., Trukhmanov, A. S., Lapina, T. L., Maslenkina, K. S., Alekseeva, A. A., Balykova, L. A., Bordin, D. S., Budkina, T. N., Bulgakova, V. A., Vakhlova, I. V., …, & Paraskevova, A. V. (2026). Current Clinical Guidelines for the Management of Patients with Eosinophilic Esophagitis. Pediatric pharmacology, 23(3), 220-251. https://doi.org/10.15690/pf.v23i3.3066
Vancouver
Drapkina OM, Ivashkin VT, Maev IV, Namazova-Baranova LS, Baranov AA, Khaitov MR, et al. Current Clinical Guidelines for the Management of Patients with Eosinophilic Esophagitis. Pediatric pharmacology. 2026;23(3):220-251. doi:10.15690/pf.v23i3.3066
BibTeX
@article{Drapkina2026,
author = {Drapkina, Oksana M. and Ivashkin, Vladimir T. and Maev, Igor V. and Namazova-Baranova, Leyla S. and Baranov, Aleksandr A. and Khaitov, Musa R. and Mikhaleva, Lyudmila M. and Kaybysheva, Valeria O. and Vishneva, Elena A. and Fedorov, Evgeniy D. and Trukhmanov, Aleksandr S. and Lapina, Tatyana L. and Maslenkina, Ksenia S. and Alekseeva, Anna A. and Balykova, Larisa A. and Bordin, Dmitriy S. and Budkina, Tatyana N. and Bulgakova, Vilya A. and Vakhlova, Irina V. and Valitova, Elen R. and Vyazankina, Svetlana S. and Gorbachev, Evgeniy V. and Ivanova, Ekaterina V. and Ilyina, Natalia I. and Kaytukova, Elena V. and Kiryukhin, Andrey P. and Kovtun, Olga P. and Komarova, Elena V. and Kornienko, Elena A. and Kuvaev, Roman O. and Kulichenko, Tatyana V. and Kurbacheva, Oksana M. and Levina, Yulia G. and Lokhmatov, Maksim M. and Makarova, Svetlana G. and Nenasheva, Natalia M. and Nikonov, Evgeniy L. and Novik, Gennadiy A. and Pavlov, Pavel V. and Paraskevova, Anna V.},
title = {Current Clinical Guidelines for the Management of Patients with Eosinophilic Esophagitis},
journal = {Pediatric pharmacology},
year = {2026},
volume = {23},
number = {3},
pages = {220--251},
doi = {10.15690/pf.v23i3.3066}
}
EUVIMED